Miller Mary (CIK 0001841088)

Latest company ownership

BFLY - Butterfly Network, Inc.
Role: General Counsel & Corp Sec
Shares held
383,512
Last filed at
Mar 24, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q1 2025Q4
ACRV - Acrivon Therapeutics, Inc.
Role: Chief Legal Officer
Shares held
34,555
Last filed at
Nov 18, 2025
Confidence Score
47.5
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Nov 14, 2025 Nov 18, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -184 -0.53% ✗ $412.2
Oct 17, 2025 Oct 21, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -558 -1.58% ✗ $1K
Oct 1, 2025 Oct 3, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -284 -0.80% ✗ $514
Aug 14, 2025 Aug 18, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -184 -0.51% ✗ $255.8
Jul 17, 2025 Jul 21, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -558 -1.54% ✗ $736.6
May 14, 2025 May 16, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -184 -0.50% ✗ $209.8
Apr 17, 2025 Apr 18, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -558 -1.51% ✗ $1K
Feb 14, 2025 Feb 19, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -217 -0.58% ✗ $1.2K
Jan 17, 2025 Jan 22, 2025 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -659 -1.74% ✗ $3.8K
Nov 14, 2024 Nov 18, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 52.5 -184 -0.48% ✗ $1.5K
Oct 17, 2024 Oct 21, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -558 -1.44% ✗ $4.4K
Oct 1, 2024 Oct 3, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -284 -0.73% ✗ $2K
Aug 14, 2024 Aug 16, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 52.5 -184 -0.47% ✗ $1.3K
Jul 17, 2024 Jul 19, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -558 -1.41% ✗ $4.3K
May 14, 2024 May 16, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 52.5 -184 -0.46% ✗ $1.5K
Apr 17, 2024 Apr 19, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -558 -1.38% ✗ $5.8K
Feb 14, 2024 Feb 16, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 50.0 -217 -0.53% ✗ $737.8
Jan 17, 2024 Jan 19, 2024 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -652 -1.58% ✗ $2.8K
Nov 14, 2023 Nov 16, 2023 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 47.5 -735 -1.75% ✗ $3.7K
Oct 17, 2023 Oct 19, 2023 Acrivon Therapeutics, Inc. Chief Legal Officer Sell 46.3 -2,232 -5.04% ✗ $12.2K
Feb 16, 2022 Feb 17, 2022 Butterfly Network, Inc. General Counsel & Corp Sec Sell 42.5 -16,677 -10.71% ✗ $99.3K